The Histone Acetyltransferase hMOF is Overexpressed in Non-small Cell Lung Carcinoma
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: One of the histone acetyltransferases (HATs) family of proteins, human MOF (hMOF, MYST1), is involved in histone H4 acetylation, particularly at lysine 16 (H4K16Ac), an epigenetic mark of active genes. Dysregulation of the epigenetic mark influences cellular biology and possibly leads to oncogenesis. We examined the involvement of hMOF and H4K16Ac in primary non-small cell lung cancer (NSCLC). Methods: Reverse transcription polymerase chain reaction using fresh-frozen lung cancer tissues and lung cancer cell lines and immunohistochemistry for hMOF and H4K16Ac via tissue microarray of 551 formalin-fixed paraffin-embedded NSCLC tissue blocks were conducted. Results: hMOF mRNA was frequently overexpressed in lung cancer tissues, compared with normal lung tissues (10/20, 50%). NSCLC tissues were positive for hMOF in 37.6% (184/489) and H4K16Ac in 24.7% (122/493) of cases. hMOF protein expression was tightly correlated with the H4K16Ac level in tumors (p<0.001). Knockdown of hMOF mRNA with siRNA led to a significant inhibition of growth in the Calu-6 cell line. Conclusions: hMOF was frequently expressed in NSCLC and was correlated with H4K16Ac. To our knowledge, this is the first study that has focused on the expression status of HATs and hMOF in NSCLC. Our results clearly suggest a potential oncogenic role of the gene and support its utility as a potential therapeutic target.
Abstract
Background: One of the histone acetyltransferases (HATs) family of proteins, human MOF (hMOF, MYST1), is involved in histone H4 acetylation, particularly at lysine 16 (H4K16Ac), an epigenetic mark of active genes. Dysregulation of the epigenetic mark influences cellular biology and possibly leads to oncogenesis. We examined the involvement of hMOF and H4K16Ac in primary non-small cell lung cancer (NSCLC). Methods: Reverse transcription polymerase chain reaction using fresh-frozen lung cancer tissues and lung cancer cell lines and immunohistochemistry for hMOF and H4K16Ac via tissue microarray of 551 formalin-fixed paraffin-embedded NSCLC tissue blocks were conducted. Results: hMOF mRNA was frequently overexpressed in lung cancer tissues, compared with normal lung tissues (10/20, 50%). NSCLC tissues were positive for hMOF in 37.6% (184/489) and H4K16Ac in 24.7% (122/493) of cases. hMOF protein expression was tightly correlated with the H4K16Ac level in tumors (p<0.001). Knockdown of hMOF mRNA with siRNA led to a significant inhibition of growth in the Calu-6 cell line. Conclusions: hMOF was frequently expressed in NSCLC and was correlated with H4K16Ac. To our knowledge, this is the first study that has focused on the expression status of HATs and hMOF in NSCLC. Our results clearly suggest a potential oncogenic role of the gene and support its utility as a potential therapeutic target.
참고문헌 (30)
- Luger K, "Crystal structure of the nucleosome core particle at 2.8 A resolution", Nature, 389, pp.251~260 (1997)
- Sims RJ 3rd, "Histone lysine methylation: a signature for chromatin function", Trends Genet, 19, pp.629~639 (2003)
- Strahl BD, "The language of covalent histone modifications", Nature, 403, pp.41~45 (2000)
- Zhang Y, "Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails", Genes Dev, 15, pp.2343~2360 (2001)
- Van Holde KE, "Chromatin" (1988), Springer
- Carrozza MJ, "The diverse functions of histone acetyltransferase complexes", Trends Genet, 19, pp.321~329 (2003)
- Eberharter A, "Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics", EMBO Rep, 3, pp.224~229 (2002)
- Gayther SA, "Mutations truncating the EP300 acetylase in human cancers", Nat Genet, 24, pp.300~303 (2000)
- Seligson DB, "Global histone modification patterns predict risk of prostate cancer recurrence", Nature, 435, pp.1262~1266 (2005)
- Cress WD, "Histone deacetylases, transcriptional control, and cancer", J Cell Physiol, 184, pp.1~16 (2000)
- Drummond DC, "Clinical development of histone deacetylase inhibitors as anticancer agents", Annu Rev Pharmacol Toxicol, 45, pp.495~528 (2005)
- Munks RJ, "Histone H4 acetylation in Drosophila: frequency of acetylation at different sites defined by immunolabelling with site-specific antibodies", FEBS Lett, 284, pp.245~248 (1991)
- Fraga MF, "Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer", Nat Genet, 37, pp.391~400 (2005)
- Mendjan S, "Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila", Mol Cell, 21, pp.811~823 (2006)
- Smith ER, "A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16", Mol Cell Biol, 25, pp.9175~9188 (2005)
- Taipale M, "hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells", Mol Cell Biol, 25, pp.6798~6810 (2005)
- Gupta A, "Involvement of human MOF in ATM function", Mol Cell Biol, 25, pp.5292~5305 (2005)
- Sykes SM, "Acetylation of the p53 DNA-binding domain regulates apoptosis induction", Mol Cell, 24, pp.841~851 (2006)
- Edge SB, "AJCC cancer staging manual. 7th ed" (2010), Springer
- Travis WD, "Pathology and genetics of tumors of the lung, pleura, thymus and heart" (2004), IARC Press
- Kononen J, "Tissue microarrays for high-throughput molecular profiling of tumor specimens", Nat Med, 4, pp.844~847 (1998)
- Livak KJ, "ABI PRISM 7700 Sequence Detection System. User bulletin No. 2. Relative quantitation of gene expression", PE Applied Biosystems, ~ (1997)
- Pfister S, "The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma", Int J Cancer, 122, pp.1207~1213 (2008)
- Brabletz T, "Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas", Am J Pathol, 156, pp.865~870 (2000)
- Gupta A, "The mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis", Mol Cell Biol, 28, pp.397~409 (2008)
- Pruitt K, "Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation", PLoS Genet, 2, pp.e40~ (2006)
- Hoeijmakers JH, "Genome maintenance mechanisms for preventing cancer", Nature, 411, pp.366~374 (2001)
- Stein CA, "Oligodeoxynucleotides as inhibitors of gene expression: a review", Cancer Res, 48, pp.2659~2668 (1988)
- Cioca DP, "RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines", Cancer Gene Ther, 10, pp.125~133 (2003)
- Yang G, "Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2", neu gene expression, 2004, pp.279, 4339~4345